Skip to main contentSkip to navigation
Sirius Investors
Nanobac Pharmaceuticals, Incorporated

Nanobac Pharmaceuticals, Incorporated

NNBP
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for NNBP. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
11.88M
N/A over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
16.00M
+840.99% over period
CAGR: +18.81%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Dec 31, 2007

EV/EBITDA

Distorted

-4.00x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

4.12M

EV is +34.7% vs equity value

Capital Structure Signal

Net Debt Profile

Trend unavailable for selected history

Additional Multiples

EV/Sales: 942.77x

Net Debt/EBITDA: -4.00x

Share count trend unavailable

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 200711.88M16.00M$0.05247.47M
Dec 31, 200623.93M29.26M$0.12199.43M
Dec 31, 20056.99M9.46M$0.04188.86M
Dec 31, 2004
Dec 31, 2003
Dec 31, 2002
Dec 31, 1999
Dec 31, 1998
Dec 31, 1997
Dec 31, 1996
Dec 31, 1995
Dec 31, 1994

Enterprise Value Analysis

Price Change (Dec 2006 to Dec 2007)

The stock price has decreased from Dec 2006 to Dec 2007.
-60.00%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
1.28

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.02

Market Cap Change (Dec 2006 to Dec 2007)

The company's market capitalization has decreased from Dec 2006 to Dec 2007.
-50.36%

Enterprise Value Change (Dec 2006 to Dec 2007)

The company's enterprise value has decreased from Dec 2006 to Dec 2007, suggesting a decline in the company's total economic value.
-45.33%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (10 periods), accounting for compounding effects.
23.47%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (10 periods), accounting for compounding effects.
7.34%